Treatment Guidelines

AHA Provides Overview of CV Risk Associated with Hormone Therapies Used in Breast, Prostate Cancer Treatment

May 05, 2021

The AHA has released a scientific statement aimed at outlining the current knowledge base related to risk of cardiovascular disease associated with hormonal therapies used in the treatment of breast and prostate cancer.

AHA/ASA Release Guidance for Treatment of COVID-19 Vaccine-Related Clotting, Low Platelet Counts

May 03, 2021

The American Heart Association and American Stroke Association have released a special report related to the treatment of blood clots or low platelet counts related to the COVID-19 vaccine, which has garnered mass amounts of attention despite being a rare complication.

USPSTF Statement Reaffirms 2015 Blood Pressure Screening Guidance

April 27, 2021

The USPSTF has released a recommendation statement related to hypertension screenings among adults without known hypertension.

Year in Review: Advances in Lipid Management During 2020

December 28, 2020

Practical Cardiology Advisory Board Member Brett Nowlan, MD, offers his perspective on the most important advances and topics in the field of lipidology from 2020.

Gregory Weiss, MD: Managing Cardiovascular Disease Risk During Menopause

December 18, 2020

Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.

Gregory Weiss, MD: Guidelines on Quality Measures for AFib

December 11, 2020

Dr. Gregory Weiss explores and gives perspective on the latest guidelines from the AHA and ACC outlining quality measures for adults with atrial fibrillation or atrial flutter

Deepak Bhatt, MD: Icosapent Ethyl and REDUCE-IT Data from ESC Congress 2020

September 04, 2020

Deepak Bhatt, MD, of Brigham and Women's Hospital, offers perspective on REDUCE-IT analyses and icosapent ethyl (Vascepa) data presented at ESC Congress 2020.

Milton Packer, MD: The Evolution of the SGLT2 Inhibitor Class

September 03, 2020

Milton Packer, MD, discusses how EMPEROR-Reduced data influences the way clinicians view the SGLT2 inhibitor class and its uses.

Physician's Perspective: Role of Dietary Assessment in Cardiovascular Disease Screening

August 18, 2020

Gregory Weiss, MD, offers his perspective on a recent scientific statement from the American Heart Association underlining the importance of dietary assessments in patients seeing a cardiologist.

Marijuana and Heart Health: What We Know and The Biggest Remaining Questions

August 10, 2020

A new scientific statement from the American Heart Association is acting as a "call to action" for greater research into the effects of marijuana, according to the statement's co-author.